Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
|Articles|August 26, 2009
Partnership for improved systems integration
Author(s)Stephanie Sutton
A transatlantic strategic partnership has been struck between California (USA) based enterprise software solution provider ValGenesis and IT integration specialists Systec & Services (Germany).
Advertisement
A transatlantic strategic partnership has been struck between California (USA) based enterprise software solution provider ValGenesis and IT integration specialists Systec & Services (Germany). The agreement establishes Systec & Services as ValGenesis' reseller and solution provider, as well as the company's integration partner for the European market.
In a
"All of our clients are talking about 'electronic' and 'paperless'; therefore, we have implemented a number of electronic batch recording solutions," Hermann Schaefer, Managing Director at Systec & Services responsible for the software solution portfolio, explained in the joint statement. "We have been looking for solutions to automate the validation and qualification processes and with ValGenesis we have found exactly what we were looking for."
Siva Samy, CEO of ValGenesis Inc. added in the statement: "Our solution offers a great level of functions and features helping customers to increase automation and operational process efficiency."
Advertisement
Related to this article
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Advertisement
Advertisement